PK and PK / PD Modeling of Bcl2 Inhibitor S65487 in Patients With AML and Investigation of Nonlinearity With Microdosing
Chloé Burlot, François Riglet, Mathilde Romagnoli, A Leconte et autres
0 citationsCPT Pharmacometrics & Systems Pharmacology
Sylvain Fouliard
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
47Publications signalées
941Citations signalées
2Affiliations récentes
Institutions déclarées
Domaines associés
CAR-T cell therapy researchAcute Lymphoblastic Leukemia researchBiosimilars and Bioanalytical MethodsStatistical Methods in Clinical TrialsMonoclonal and Polyclonal Antibodies Research
Publications récentes
PKPD-Based Translational Modeling of Calaspargase Pegol Preclinical Activity in Hepatocellular Carcinoma
Eef Hoeben, Vincent Madelain, Chayan Acharya, Pierre Barbier Saint Hilaire et autres
0 citationsEuropean Journal of Drug Metabolism and Pharmacokinetics
The Evolving Role of In Vitro–In Vivo Correlation in Model‐Informed Drug Development: A Multi‐Stakeholder Perspective
Marylore Chenel, Sylvain Fouliard, Emma Hansson, Karl Brendel et autres
4 citationsCPT Pharmacometrics & Systems Pharmacology
Virtual patients inspired by multiomics predict the efficacy of an anti-IFNα mAb in cutaneous lupus
Vincent Hurez, Glenn Gauderat, Perrine Soret, R. C. Myers et autres
5 citationsiScience
Quantitative systems pharmacology modeling of tumor heterogeneity in response to BH3 ‐mimetics using virtual tumors calibrated with cell viability assays
Thibaud Derippe, Sylvain Fouliard, Xavier Declèves, Donald E. Mager
2 citationsCPT Pharmacometrics & Systems Pharmacology
Peer Review Report For: Peccary, a metaprogramming open-source R platform to improve pharmacometrics efficiency [version 1; peer review: 1 approved, 1 approved with reservations]
Thibaud Derippe, Xavier Declèves, Sylvain Fouliard
0 citations
Data from Clinical Pharmacology and Determinants of Response to UCART19, an Allogeneic Anti-CD19 CAR-T Cell Product, in Adult B-cell Acute Lymphoblastic Leukemia
Sandra Dupouy, Ibtissam Marchiq, Thibaud Derippe, Maria Almena-Carrasco et autres
0 citations
Data from Mechanistic Modeling of the Interplay Between Host Immune System, IL-7 and UCART19 Allogeneic CAR-T Cells in Adult B-cell Acute Lymphoblastic Leukemia
Thibaud Derippe, Sylvain Fouliard, Ibtissam Marchiq, Sandra Dupouy et autres
0 citations
Supplementary Tables S1-S4 from Clinical Pharmacology and Determinants of Response to UCART19, an Allogeneic Anti-CD19 CAR-T Cell Product, in Adult B-cell Acute Lymphoblastic Leukemia
Sandra Dupouy, Ibtissam Marchiq, Thibaud Derippe, Maria Almena-Carrasco et autres
0 citations
Supplementary Data S1 from Mechanistic Modeling of the Interplay Between Host Immune System, IL-7 and UCART19 Allogeneic CAR-T Cells in Adult B-cell Acute Lymphoblastic Leukemia
Thibaud Derippe, Sylvain Fouliard, Ibtissam Marchiq, Sandra Dupouy et autres
0 citations
Supplementary Materials & Methods SM1 from Clinical Pharmacology and Determinants of Response to UCART19, an Allogeneic Anti-CD19 CAR-T Cell Product, in Adult B-cell Acute Lymphoblastic Leukemia
Sandra Dupouy, Ibtissam Marchiq, Thibaud Derippe, Maria Almena-Carrasco et autres
0 citations
Supplementary Figures S1-S9 from Clinical Pharmacology and Determinants of Response to UCART19, an Allogeneic Anti-CD19 CAR-T Cell Product, in Adult B-cell Acute Lymphoblastic Leukemia
Sandra Dupouy, Ibtissam Marchiq, Thibaud Derippe, Maria Almena-Carrasco et autres
0 citations
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.